Last updated 26 July 2026
These terms apply when a clinic engages Novelle Growth to run advertising campaigns. They sit alongside the short written proposal we send you, which sets out your fee, your treatment categories and your agreed enquiry baseline. Where the two disagree, the proposal wins.
“We” and “us” means JMD Brands Limited, trading as Novelle Growth, registered in England and Wales, company number 16492279, registered office 20–22 Wenlock Road, London N1 7GU. “You” means the clinic or company named in the proposal.
We generate patient enquiries through paid social advertising, principally Meta. That includes strategy, writing and building the ads from imagery and footage you supply, building the landing page and enquiry form, managing the ad accounts day to day, and reporting weekly.
We do not produce photography or video, we do not staff your phones, and we do not contact or follow up your enquiries. Converting an enquiry into a booked and attended appointment is your responsibility.
Your first calendar month of management is free of charge. Ad spend is still payable by you during that month.
Before launch we agree, in writing, the number of enquiries your clinic receives in a normal month. That figure is your baseline. If in the 30 days following your first ad going live the campaigns have not produced more qualified enquiries than the baseline, we will refund any management fee you have paid for that period.
The guarantee is limited to a refund of management fees paid. It does not cover your ad spend, and it applies once per client.
The engagement runs month to month. Either of us may end it by giving 30 days’ notice in writing by email. Fees already invoiced for the current month remain payable. We may end it immediately if an invoice stays unpaid, or if we are asked to run advertising we believe is misleading or non-compliant.
You give us access to your ad accounts and page, imagery and footage of your clinic and treatments, accurate pricing and treatment information, and a named person who can approve creative within two working days. You confirm that any before-and-after imagery you supply has documented patient consent for advertising use.
Delays in approvals or missing materials will delay launch, and the 30 day guarantee period starts only once ads are live.
We write to ASA and CAP guidance and, where relevant, CQC and GDC advertising rules. Prescription-only medicines, including botulinum toxin, will never be named or promoted in advertising we run for you.
You remain responsible for the clinical and regulatory accuracy of any claim, price or qualification you ask us to publish, and for your own registration and insurance. You approve all creative before it runs.
Your ad accounts, pixels, page, imagery and the enquiry data all remain yours and stay in your name. Once fees are paid, the ad copy and landing page we produce for you are yours to keep and continue using. Our internal templates, frameworks and processes remain ours. We may describe the work and results anonymously as a case study unless you ask us in writing not to.
We limit how many clinics we take per treatment category per city so we are not competing against our own clients. Your proposal states the category and area held for you while the engagement is live.
Advertising results vary and we cannot promise specific revenue, bookings or patient numbers beyond the guarantee in clause 3. We are not liable for platform decisions outside our control, including account restrictions or ad rejections by Meta.
Our total liability in any 12 month period is limited to the management fees you paid us in that period. Neither of us is liable for loss of profit, goodwill or indirect loss. Nothing here limits liability for death, personal injury or fraud.
For patient enquiries generated by campaigns, you are the controller and we are the processor. We handle that data only on your instructions and delete it from our systems within 90 days of passing it to you. Our privacy policy sets out the detail.
These terms are governed by the law of England and Wales, and the courts of England and Wales have exclusive jurisdiction.